Save your place

Sign in to WhoBought

Please try again later.

Catalyst Pharmaceuticals, Inc. (CPRX) institutional ownership

Latest close $31.49 Jul 17, 2026
Market cap$3.0B 52-week range SectorHealthcare
Funds holding · Q1 2026
354
reported CPRX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net bought $7.7M
194 buyers · 160 sellers

Catalyst Pharmaceuticals, Inc. (CPRX) price and institutional activity

Dates

Q1 2026

$271M bought by 194 investors
American Century Companies Inc$27MBank of America Corp$20M +192 more
$264M sold by 160 investors
Fundsmith LLP-$60MDeerfield Management Company, L.P.-$23M +158 more
Bought Sold Totals per quarter; hover a bar for the names.

Catalyst Pharmaceuticals, Inc. (CPRX) institutional activity · 354

Investor Type Est. change Change Δ Own Date
Fundsmith LLP · Reduced −$60M
Change −2.5M Δ Own −74.9% Date Q1 2026
Fundsmith LLP Reduced· Q1 2026 −$60M −2.5M −74.9% Q1 2026
American Century Companies Inc · Added +$27M
Change +1.1M Date Q1 2026
American Century Companies Inc Added· Q1 2026 +$27M +1.1M Q1 2026
Deerfield Management Company, L.P. · Reduced −$23M
Change −968K Date Q1 2026
Deerfield Management Company, L.P. Reduced· Q1 2026 −$23M −968K Q1 2026
Bank of America Corp · Added +$20M
Change +837K Date Q1 2026
Bank of America Corp Added· Q1 2026 +$20M +837K Q1 2026
Susquehanna International Group, LLP · Added +$16M
Change +689K Date Q1 2026
Susquehanna International Group, LLP Added· Q1 2026 +$16M +689K Q1 2026
Arrowstreet Capital, Limited Partnership · Reduced −$16M
Change −662K Date Q1 2026
Arrowstreet Capital, Limited Partnership Reduced· Q1 2026 −$16M −662K Q1 2026
Clark Capital Management Group, Inc. · New +$14M
Change +569K Date Q1 2026
Clark Capital Management Group, Inc. New· Q1 2026 +$14M +569K Q1 2026
Imc-Chicago, LLC · New +$13M
Change +564K Date Q1 2026
Imc-Chicago, LLC New· Q1 2026 +$13M +564K Q1 2026
Invesco Ltd. · Reduced −$13M
Change −541K Δ Own −41.8% Date Q1 2026
Invesco Ltd. Reduced· Q1 2026 −$13M −541K −41.8% Q1 2026
Metlife Investment Management, LLC · Reduced −$13M
Change −528K Date Q1 2026
Metlife Investment Management, LLC Reduced· Q1 2026 −$13M −528K Q1 2026
Legal & General · Reduced −$12M
Change −506K Date Q1 2026
Legal & General Reduced· Q1 2026 −$12M −506K Q1 2026
Boston Partners · Added +$11M
Change +480K Date Q1 2026
Boston Partners Added· Q1 2026 +$11M +480K Q1 2026
William Blair Investment Management, LLC · New +$11M
Change +479K Date Q1 2026
William Blair Investment Management, LLC New· Q1 2026 +$11M +479K Q1 2026
Dimensional · Added +$10M
Change +433K Date Q1 2026
Dimensional Added· Q1 2026 +$10M +433K Q1 2026
Point72 Asset Management, L.P. · New +$10M
Change +426K Date Q1 2026
Point72 Asset Management, L.P. New· Q1 2026 +$10M +426K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 354

Famous investor activity in Catalyst Pharmaceuticals, Inc. (CPRX)

Catalyst Pharmaceuticals, Inc. (CPRX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Elsbernd Brian · Officer 11 operations -1.2M
Price $31.50 Owned 0 Trade date Jul 15, 2026 Filed date Jul 17, 2026
Elsbernd Brian Officer 11 operations $31.50 -1.2M 0 Jul 15, 2026 Jul 17, 2026
Curran Daniel J. · Director 3 operations -64K
Owned 0 Trade date Jul 15, 2026 Filed date Jul 17, 2026
Curran Daniel J. Director 3 operations -64K 0 Jul 15, 2026 Jul 17, 2026
Tierney David S. · Director 11 operations -561K
Price $31.50 Owned 0 Trade date Jul 15, 2026 Filed date Jul 17, 2026
Tierney David S. Director 11 operations $31.50 -561K 0 Jul 15, 2026 Jul 17, 2026
Miller Steve · Officer 11 operations -2.6M
Price $31.50 Owned 0 Trade date Jul 15, 2026 Filed date Jul 17, 2026
Miller Steve Officer 11 operations $31.50 -2.6M 0 Jul 15, 2026 Jul 17, 2026
Thompson Tamar · Director 8 operations -123K
Price $31.50 Owned 0 Trade date Jul 15, 2026 Filed date Jul 17, 2026
Thompson Tamar Director 8 operations $31.50 -123K 0 Jul 15, 2026 Jul 17, 2026
Russo Gregg · Officer 7 operations -72K
Price $31.50 Owned 0 Trade date Jul 15, 2026 Filed date Jul 17, 2026
Russo Gregg Officer 7 operations $31.50 -72K 0 Jul 15, 2026 Jul 17, 2026
McEnany Patrick J. · Director 11 operations -6.0M
Price $31.50 Owned 0 Trade date Jul 15, 2026 Filed date Jul 17, 2026
McEnany Patrick J. Director 11 operations $31.50 -6.0M 0 Jul 15, 2026 Jul 17, 2026
Denkhaus Donald A. · Director 11 operations -677K
Price $31.50 Owned 0 Trade date Jul 15, 2026 Filed date Jul 17, 2026
Denkhaus Donald A. Director 11 operations $31.50 -677K 0 Jul 15, 2026 Jul 17, 2026
Del Carmen Jeffrey · Officer 11 operations -1.1M
Price $31.50 Owned 0 Trade date Jul 15, 2026 Filed date Jul 17, 2026
Del Carmen Jeffrey Officer 11 operations $31.50 -1.1M 0 Jul 15, 2026 Jul 17, 2026
Sundaram Preethi · Officer 10 operations -853K
Price $31.50 Owned 0 Trade date Jul 15, 2026 Filed date Jul 17, 2026
Sundaram Preethi Officer 10 operations $31.50 -853K 0 Jul 15, 2026 Jul 17, 2026
Daly Richard J. · Director 11 operations -2.9M
Price $31.50 Owned 0 Trade date Jul 15, 2026 Filed date Jul 17, 2026
Daly Richard J. Director 11 operations $31.50 -2.9M 0 Jul 15, 2026 Jul 17, 2026
Andrews William T. · Officer 5 operations -267K
Price $31.50 Owned 0 Trade date Jul 15, 2026 Filed date Jul 17, 2026
Andrews William T. Officer 5 operations $31.50 -267K 0 Jul 15, 2026 Jul 17, 2026
Harper Molly · Director 10 operations -131K
Price $31.50 Owned 0 Trade date Jul 15, 2026 Filed date Jul 17, 2026
Harper Molly Director 10 operations $31.50 -131K 0 Jul 15, 2026 Jul 17, 2026
Kalb Michael Wayne · Officer 7 operations -647K
Price $31.50 Owned 0 Trade date Jul 15, 2026 Filed date Jul 17, 2026
Kalb Michael Wayne Officer 7 operations $31.50 -647K 0 Jul 15, 2026 Jul 17, 2026
Andrews William T. · Officer Exercise or conversion (M/X/C) 3K
Owned 3K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Andrews William T. Officer Exercise or conversion (M/X/C) 3K 3K Jun 3, 2026 Jun 5, 2026
15 of 57
15 of 57 Sign in to continue to older insider transactions.

Catalyst Pharmaceuticals, Inc. (CPRX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Blackrock, Inc. 19.0M
% of shares outstanding 16.0% Filing date Nov 8, 2024
Blackrock, Inc. 19.0M 16.0% Nov 8, 2024
BlackRock Inc. 15.8M
% of shares outstanding 14.8% Filing date Jan 22, 2024
BlackRock Inc. 15.8M 14.8% Jan 22, 2024
Vanguard Group Inc 7.1M
% of shares outstanding 6.7% Filing date Feb 13, 2024
Vanguard Group Inc 7.1M 6.7% Feb 13, 2024
Flynn James E 6.2M
% of shares outstanding 5.2% Filing date Nov 14, 2024
Flynn James E 6.2M 5.2% Nov 14, 2024
State Street Corp 5.7M
% of shares outstanding 4.8% Filing date Oct 17, 2024
State Street Corp 5.7M 4.8% Oct 17, 2024
Armistice Capital, LLC
% of shares outstanding 0.0% Filing date Feb 14, 2023
Armistice Capital, LLC 0.0% Feb 14, 2023
6 of 6

Catalyst Pharmaceuticals, Inc. (CPRX) ownership FAQ

Who owns CPRX?

354 reporting institutions disclosed CPRX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.